136 related articles for article (PubMed ID: 1371665)
21. Platelet function during cardiopulmonary bypass not changed by two different doses of aprotinin.
Santamaría A; Mateo J; Muñíz-Díaz E; Oliver A; Murillo J; Litvan H; Souto JC; Fontcuberta J
Haematologica; 2000 Apr; 85(4):381-5. PubMed ID: 10756363
[TBL] [Abstract][Full Text] [Related]
22. Aprotinin effect on platelet function and clotting during cardiopulmonary bypass.
Tabuchi N; De Haan J; Boonstra PW; Huet RC; van Oeveren W
Eur J Cardiothorac Surg; 1994; 8(2):87-90. PubMed ID: 7513534
[TBL] [Abstract][Full Text] [Related]
23. Aprotinin counteracts heparin-induced inhibition of platelet contractile force.
Carr ME; Carr SL; Roa V; McCardell KA; Greilich PE
Thromb Res; 2002 Nov; 108(2-3):161-8. PubMed ID: 12590953
[TBL] [Abstract][Full Text] [Related]
24. Blood conservation techniques and platelet function in cardiac surgery.
Boldt J; Zickmann B; Czeke A; Herold C; Dapper F; Hempelmann G
Anesthesiology; 1991 Sep; 75(3):426-32. PubMed ID: 1716079
[TBL] [Abstract][Full Text] [Related]
25. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
[TBL] [Abstract][Full Text] [Related]
26. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
[TBL] [Abstract][Full Text] [Related]
27. Hypothermia-induced platelet aggregation: no effect of aprotinin (trasylol) but inhibition by eptifibatide (integrilin).
Straub A; Azevedo R; Beierlein W; Wendel HP; Scheule AM; Ziemer G
Thorac Cardiovasc Surg; 2005 Apr; 53(2):80-4. PubMed ID: 15786005
[TBL] [Abstract][Full Text] [Related]
28. Platelet function in cardiac surgery: influence of temperature and aprotinin.
Boldt J; Knothe C; Zickmann B; Bill S; Dapper F; Hempelmann G
Ann Thorac Surg; 1993 Mar; 55(3):652-8. PubMed ID: 7680852
[TBL] [Abstract][Full Text] [Related]
29. [Aprotinin in cardiac surgery in patients with platelet anti-aggregant treatment].
Bertrand P; Mazzucotelli JP; Loisance D; Elsayed A; Deleuze P; Cachera JP
Arch Mal Coeur Vaiss; 1993 Oct; 86(10):1471-4. PubMed ID: 7516648
[TBL] [Abstract][Full Text] [Related]
30. Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation.
Day JR; Haskard DO; Taylor KM; Landis RC
Ann Thorac Surg; 2006 Feb; 81(2):619-24. PubMed ID: 16427862
[TBL] [Abstract][Full Text] [Related]
31. "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release.
Ashraf S; Tian Y; Cowan D; Nair U; Chatrath R; Saunders NR; Watterson KG; Martin PG
Ann Thorac Surg; 1997 Jan; 63(1):68-73. PubMed ID: 8993243
[TBL] [Abstract][Full Text] [Related]
32. Hemostatic function of aspirin-treated platelets vulnerable to cardiopulmonary bypass. Altered shear-induced pathway.
Tabuchi N; Huet RC; Sturk A; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1995 Sep; 110(3):813-8. PubMed ID: 7564450
[TBL] [Abstract][Full Text] [Related]
33. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass.
van Oeveren W; Jansen NJ; Bidstrup BP; Royston D; Westaby S; Neuhof H; Wildevuur CR
Ann Thorac Surg; 1987 Dec; 44(6):640-5. PubMed ID: 2446574
[TBL] [Abstract][Full Text] [Related]
34. [Reduction of postoperative blood loss and donor blood use in heart surgery with aprotinin: experience with various dosages].
Carrel T; Bauer E; Garcia E; von Segesser L; Niederhäuser U; Schönbeck M; Laske A; Turina M
Helv Chir Acta; 1991 Sep; 58(3):365-78. PubMed ID: 1722785
[TBL] [Abstract][Full Text] [Related]
35. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
[TBL] [Abstract][Full Text] [Related]
36. Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass.
Khalil PN; Ismail M; Kalmar P; von Knobelsdorff G; Marx G
Thromb Haemost; 2004 Sep; 92(3):568-74. PubMed ID: 15351853
[TBL] [Abstract][Full Text] [Related]
37. A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations.
Fish KJ; Sarnquist FH; van Steennis C; Mitchell RS; Hilberman M; Jamieson SW; Linet OI; Miller DC
J Thorac Cardiovasc Surg; 1986 Mar; 91(3):436-42. PubMed ID: 3512919
[TBL] [Abstract][Full Text] [Related]
38. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation.
Verma YS; Chauhan S; Bisoi AK; Gharde P; Kiran U; Das SN
Ann Card Anaesth; 2010; 13(2):110-5. PubMed ID: 20442540
[TBL] [Abstract][Full Text] [Related]
39. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
[TBL] [Abstract][Full Text] [Related]
40. Platelet anesthesia with nitric oxide with or without eptifibatide during cardiopulmonary bypass in baboons.
Suzuki Y; Malekan R; Hanson CW; Niewiarowski S; Sun L; Rao AK; Edmunds LH
J Thorac Cardiovasc Surg; 1999 May; 117(5):987-93. PubMed ID: 10220694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
